Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that it has entered into a license agreement and collaboration with MedImmune, the global biologics research and development arm …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that its DNA-based monoclonal antibody (dMAb) targeting dengue virus provided protection against a lethal dengue virus challenge in mice. …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that it has initiated a phase I trial to evaluate Inovio’s DNA immunotherapy in men with biochemically relapsed prostate …
Maxim analyst Jason Kolbert came out today with a favorable report on Inovio Pharmaceuticals Inc (NASDAQ:INO), after the company announced that it will collaborate with the European …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that it is collaborating with the European Organization for Research and Treatment of Cancer (EORTC) to evaluate Inovio’s immunotherapy, …
Inovio Pharmaceuticals Inc (NASDAQ:INO) announced that its Chief Executive Officer, Dr. J.
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) announced that Inovio’s Chief Executive Officer, Dr.
In a research report issued today, Brean Capital analyst Jonathan Aschoff reiterated a Buy rating on Inovio Pharmaceuticals Inc (NASDAQ:INO) with a $20 price …
Glu Mobile Inc. (NASDAQ:GLUU) shares jumped 22.
Inovio Pharmaceuticals Inc (Nasdaq:INO), announced that it intends to offer and sell shares of its common stock in an underwritten public offering. Piper Jaffray & …
